Chinenye Ezike, DPM
Foot & Ankle Surgery · Beckley, WVNPI 1992155576
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (42.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Mid-atlantic Surgical Systems, LLC at 30.2% of the total. Reporting peaked in 2023 at $5,843 and has fallen 93.4% since, to $385 in 2025.
Across 145 payments — averaging $78.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mid-atlantic Surgical Systems, LLC$3K
- Arthrex$2K
- Stryker$1K
- Paragon 28, Inc.$769
- Pinnacle, Inc$765
- Organogenesis Inc.$635
- plus $2K from 22 others
What the payments were for
- Travel & lodging$4,84442%
- Food & beverage$3,39430%
- Education$3,16528%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mid-atlantic Surgical Systems, LLC | 9 | $3,442 |
| Arthrex | 20 | $2,461 |
| Stryker | 10 | $1,454 |
| Paragon 28, Inc. | 5 | $769 |
| Pinnacle, Inc | 1 | $765 |
| Organogenesis Inc. | 30 | $635 |
| Smith+Nephew | 15 | $392 |
| Kerecis Limited | 4 | $207 |
| Paratek Pharmaceuticals, Inc. | 9 | $185 |
| Amgen(2 entities) | 7 | $128 |
| Boston Scientific | 1 | $118 |
| ETS Wound Care LLC | 3 | $117 |
| Averitas Pharma Inc. | 2 | $114 |
| Treace Medical Concepts, Inc. | 3 | $87 |
| Lifenet Health | 4 | $84 |
| AbbVie | 4 | $78 |
| Tactile Systems Technology Inc | 3 | $54 |
| Convatec Inc. | 2 | $53 |
| Vertex | 2 | $46 |
| Melinta Therapeutics, LLC | 2 | $35 |
| BD | 1 | $28 |
| Bioventus LLC | 2 | $28 |
| Abbott | 1 | $26 |
| Zimvie Inc. | 1 | $23 |
| Zimmer Biomet | 1 | $23 |
| Hydrofera LLC | 1 | $20 |
| Advanced Oxygen Therapy Inc. | 1 | $17 |
| ANI Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROstep$700
- INBONE$600
- Portfolio$597
- GRAFIX PL$124
- Puraply Antimicrobial$121
- GENERAL ANGIOPLASTY$118
How this compares
$11,403 in reported general payments places this provider in the 80th percentile of 36 foot & ankle surgery providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 14 | $5,316 |
| Ammonium Lactate | 61 | $1,268 |
| Ketoconazole | 46 | $1,007 |
| Gentamicin Sulfate | 33 | $900 |
| Mupirocin | 84 | $632 |
| Doxycycline Hyclate | 63 | $524 |
| Methylprednisolone | 17 | $397 |
| Levofloxacin | 34 | $248 |
| Fluconazole | 18 | $219 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 36 | $211 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $106 |
| Meloxicam | 28 | $99 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $76 |
| Tramadol Hcl | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $392 | $5,31614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 36 foot & ankle surgery providers in West Virginia.
Other foot & ankle surgery in Beckley
- Blake WeeksBeckley$4K
- Stefan LorinczBeckley$4K
- Ernest LuczkowskiBeckley$939
- Michael GentileHuntington$103K
- Carrie FrameCharleston$99K
- Kevin BrownHuntington$31K
- Jana AtikParkersburg$17K
- Kristin SilinskiParkersburg$16K
- Bradley HoffmanPrinceton$14K
- James PipesRipley$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.